-Frontline Despite the negative observations and criticisms, there is a strong case for MGNREGS works to be continued even in States with high per capita incomes. Hisar and Fatehabad: CONTRARY to general opinion, demand for work under the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS) is high in Haryana. Contrary also to the views in recent discussion papers, one of them commissioned by the Commission for Agricultural Cost and Prices...
More »SEARCH RESULT
Total Matching Records found : 646
Union Cabinet approves regulator for real estate, lays down norms to help home buyers
-The Times of India NEW DELHI: The Union Cabinet on Tuesday cleared a legislation to set up a long-pending real estate regulator aiming to protect home buyers from unscrupulous developers and builders. A real estate regulator - to be set up in every state - will ensure that private developers get all their projects registered with it before sale and only after obtaining all necessary clearances. "It will be mandatory for developers under...
More »Ponzi puzzle stumps Amway
-The Telegraph The sudden arrest of Amway India's top brass on Monday has focused the spotlight on the crumbling fault lines and the grey areas in the demarcation between some of the world's best-known direct selling companies and the dodgy Ponzi schemes that promise huge returns to gullible investors and have lately grabbed all the sensational headlines in Bengal. William S. Pinckney, managing director of Amway India, and two directors of the...
More »Drugs, Ranbaxy and lies
-The Hindu Seven years after the first warning in June 2006 from the U.S. Food and Drug Administration (FDA) and five years after the Department of Justice initiated legal proceedings against the company, Ranbaxy is back in the news for the same wrong reasons. Last fortnight it pleaded guilty to felony charges in the U.S., admitting to selling adulterated drugs with intent to deFraud, not reporting that its drugs failed...
More »More trouble for Ranbaxy as drug boycott to continue
-The Business Standard After the US and Indian authorities, the medicines manufactured by Ranbaxy Laboratories are now under the scanner of hospitals, too. Mumbai's leading Jaslok Hospital has already put up a notice advising its doctors to avoid prescribing Ranbaxy drugs, while some others are reviewing the matter. Medanta Medicity officials say they will soon assess the situation and take a decision. "I have received around a dozen queries from patients recently....
More »
